CN Stock MarketDetailed Quotes

002864 Shaanxi Panlong Pharmaceutical

Watchlist
  • 32.14
  • +0.58+1.84%
Market Closed Dec 13 15:00 CST
3.42BMarket Cap29.46P/E (TTM)

About Shaanxi Panlong Pharmaceutical Company

The company was founded in 1997 and is a modern high-tech enterprise integrating GAP cultivation of medicinal herbs, pharmaceutical production, R&D, sales and pharmaceutical logistics as its core industries. In 2016, it entered the “Top 100 Enterprises in Shaanxi” and was listed on A-shares on the Shenzhen Stock Exchange in November 2017. From 2018 to 2022, it has been on the list of China's top 100 pharmaceutical industry for five consecutive years. The company is a modern high-tech enterprise integrating standardized cultivation of medicinal herbs, pharmaceutical production, R&D, sales, and pharmaceutical logistics as its core industries. The main products are Panlong 7 tablets, white peony total glycosides capsules, paralysis capsules, paralysis tablets, Panlong 7 medicinal liquor, bone pine treasure tablets, Jinyinli Gall capsules, Kibi hot tablets, compound cotton phenol acetate tablets, motherwort granules, Shenling Baishu San, children's maizou chewable tablets, pediatric pharyngeal flat granules, bone gum Guizhen tablets, coenzyme Q10, chondroitin sulfate calcium tablets, melatonin tablets, Ganoderma lucidum spore powder, Panlong Qi Cream, Panlong Moisturizing and Repairing Mask, Panlong Astragalus, Pueraria Konjac Health Mask, Panlong Astragalus Tea, Panlong Seven Joint Health Care, Acupoint Stimulation Patch, etc. Corporate honors: AAA credit customers; model taxpayers; science and technology demonstration enterprises; AAA enterprises with quality service reputation in China; famous trademarks in Shaanxi Province; high-tech enterprises, etc. For many years in a row, it has been honored as a “Chinese Household Medication List Brand” product, a “Recommended Consumer Brand in the Traditional Chinese Medicine Market” product, and an “Ingenious Product”. The company won the 6th China Excellent IR “Best Shareholder Relationship Award” and won the honor of “2022 Excellent Investor Relations Management Unit”.

Company Profile

Short Name-A盘龙药业
Symbol-A002864
Company NameShaanxi Panlong Pharmaceutical Group Limited By Share Ltd
Listing DateNov 16, 2017
Issue Price10.03
Shares Offered21.67M share(s)
FoundedSep 22, 1997
Listed ExchangeSZ Stock Exchange
Legal Representativexiaolin xie
General Managerdezhudai zhang
Secretaryjie wu
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativexiaoni zhao
Legal CounselBeijing Ruiqiang Law Firm
Employees637
Phone029-83338888-8832
Office AddressNo. 2801, Baliu 2nd Road, Baqiao District, Xi'an, Shaanxi
Zip Code710025
Registered AddressXishui Panlong Ecological Industrial Park, Shangluo City, Shaanxi Province
Fax029-83592658
Email1970wujie@163.com
Business License610000100202319
BusinessGeneral projects: medical research and experimental development; sales of hygiene products and disposable medical supplies; sales of disinfectants (excluding hazardous chemicals); acquisition of Chinese herbal medicines; sales of class II medical devices; sale of class I medical devices; production of first class medical devices; retail of cosmetics (except for projects subject to approval by law, independently carry out business activities according to law with a business license). License items: Pharmaceutical import and export; technology import and export; import and export agency; pharmaceutical production; disinfectant production (excluding hazardous chemicals); production of hygiene products and disposable medical supplies; contract production of pharmaceuticals; import and export of goods; disinfection equipment production; drug retail; road cargo transportation (excluding dangerous goods); Class II medical device production; Class III medical device production; Class III medical device management; cosmetics production; health products (non-food) sales; health food sales; food production; food business (sales pre-packaging) Food); production of formula food for special medical purposes; sale of formula food for special medical purposes; Internet sales of food (sale of pre-packaged food); Internet sales of food (for projects subject to approval according to law, business activities can only be carried out after approval by relevant departments; specific business projects are subject to approval). (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • xiaolin xie
  • Chairman, Directors, Chairman of the Strategy Committee
  • 386.80K
  • jie wu
  • Directors, Board Secretary
  • 168.00K
  • dezhu zhang
  • Directors, Deputy General Manager, Acting President, Strategy Committee Members
  • 153.90K
  • zhihong zhang
  • Directors, Nomination Committee Members
  • 126.00K
  • xiaofeng xie
  • Directors, Audit Committee Members, Member of the Remuneration and Assessment Committee
  • --
  • jilin huang
  • Directors, Deputy General Manager
  • 315.50K
  • haiyun ren
  • Independent Directors, Chairman of the Audit Committee, Member of the Remuneration and Assessment Committee
  • 80.00K
  • leipeng jiao
  • Independent Directors, Nomination Committee Members, Audit Committee Members, Chairman of the Remuneration and Assessment Committee
  • 80.00K
  • xiaofeng niu
  • Independent Directors, Chairman of the Nomination Committee, Strategy Committee Members
  • 80.00K
  • xiaoni zhao
  • Securities Affairs Representative
  • --
  • qingshui luo
  • Chairman of the Supervisory Board, Shareholder Supervisors
  • 127.90K
  • wenfeng zhu
  • Shareholder Supervisors
  • 180.90K
  • hui ma
  • Shareholder Supervisors
  • 71.90K
  • zhong meng
  • Deputy General Manager
  • 216.10K
  • fengming zhu
  • Chief Financial Officer
  • 128.40K
  • tailin xiong
  • Employee Supervisors
  • 113.80K
  • zhekun chen
  • Employee Supervisors
  • 371.80K